| # | Drug | Count |
|---|---|---|
| 0 | RIFAXIMIN | 862 |
| 1 | LACTULOSE | 654 |
| 2 | FUROSEMIDE | 481 |
| 3 | SPIRONOLACTONE | 364 |
| 4 | DIVALPROEX SODIUM | 325 |
| 5 | OMEPRAZOLE MAGNESIUM | 250 |
| 6 | VALPROIC ACID | 232 |
| 7 | LENVATINIB | 224 |
| 8 | GLYCEROL PHENYLBUTYRATE | 207 |
| 9 | ACETAMINOPHEN | 205 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGZILARGINASE-NBLN | 8 | 0.2581 |
| 1 | GLYCEROL PHENYLBUTYRATE | 207 | 0.1487 |
| 2 | CARGLUMIC ACID | 92 | 0.1222 |
| 3 | SODIUM PHENYLBUTYRATE | 32 | 0.0758 |
| 4 | LACTULOSE SOLUTION USP, 10 G/15 ML | 5 | 0.0495 |
| 5 | RIFAXIMIN | 862 | 0.0404 |
| 6 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 12 | 0.0349 |
| 7 | L-ARGININE | 7 | 0.0195 |
| 8 | LACTULOSE | 654 | 0.0169 |
| 9 | LEVOCARNITINE | 39 | 0.0106 |
| # | Drug class | Count |
|---|---|---|
| 0 | Rifamycin Antibacterial [EPC] | 863 |
| 1 | Osmotic Laxative [EPC] | 740 |
| 2 | Loop Diuretic [EPC] | 531 |
| 3 | Kinase Inhibitor [EPC] | 446 |
| 4 | Anti-epileptic Agent [EPC] | 418 |
| 5 | Benzodiazepine [EPC] | 412 |
| 6 | Mood Stabilizer [EPC] | 372 |
| 7 | Aldosterone Antagonist [EPC] | 368 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 345 |
| 9 | Proton Pump Inhibitor [EPC] | 268 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Platelet-derived Growth Factor [EPC] | 1 | 1.0000 |
| 1 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 92 | 0.1220 |
| 2 | Rifamycin Antibacterial [EPC] | 863 | 0.0238 |
| 3 | Carnitine Analog [EPC] | 39 | 0.0106 |
| 4 | Provitamin D2 Compound [EPC] | 184 | 0.0062 |
| 5 | Medium-chain Triglyceride [EPC] | 2 | 0.0036 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 7 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 3 | 0.0033 |
| 8 | Asparagine-specific Enzyme [EPC] | 44 | 0.0033 |
| 9 | Methylating Agent [EPC] | 3 | 0.0029 |